Risk Factors and Postoperative Complications of Lobectomy for Non-Small Cell Lung Cancer: An Exploratory Analysis of Premedication and Clinical Variables
Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
MH CZ - DRO (FNOs/2024)
University Hospital Ostrava
PubMed
39768967
PubMed Central
PMC11678637
DOI
10.3390/medicina60122088
PII: medicina60122088
Knihovny.cz E-zdroje
- Klíčová slova
- lobectomy, lung cancer, postoperative complication, postoperative pneumonia, premedication, risk factors, thoracic surgery,
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory plic * chirurgie MeSH
- nemalobuněčný karcinom plic * chirurgie MeSH
- pneumektomie * škodlivé účinky metody MeSH
- pneumonie etiologie epidemiologie prevence a kontrola MeSH
- pooperační komplikace * prevence a kontrola etiologie epidemiologie MeSH
- premedikace * metody MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Background and Objectives: Postoperative pneumonia and complications significantly impact outcomes in thoracic surgery, particularly for patients undergoing lobectomy for non-small cell lung cancer (NSCLC). This study evaluates whether preoperative premedication influences the risk of postoperative pneumonia and overall complications. Materials and Methods: This retrospective study included 346 patients who underwent lobectomy for NSCLC at the University Hospital Ostrava between 2015 and 2021. Data on demographic variables, tumour staging, surgical approach, and premedication (anticholinergics, benzodiazepines, antihistamines, and analgesics) were analysed. Postoperative outcomes included pneumonia and complications classified by the modified Clavien-Dindo system. Results: Premedication was not significantly associated with postoperative pneumonia (10.7%) or overall complications (26.0%). Tumour size was the only factor significantly associated with complications, with larger tumours increasing the odds (OR: 1.16, p = 0.032). Other factors, including age, ASA classification, BMI, and surgical approach, did not demonstrate significant associations with postoperative outcomes. Conclusions: Premedication does not appear to significantly influence the risk of postoperative pneumonia or overall complications in patients undergoing lobectomy for NSCLC. Similarly, other clinical variables, such as age, ASA classification, BMI, and surgical approach, also did not show significant associations with these outcomes. These findings suggest that premedication can be individualised without increasing postoperative risks. However, tumour size emerged as a significant factor associated with complications, highlighting the need for careful preoperative assessment and planning, particularly in patients with larger tumours.
Zobrazit více v PubMed
McIntyre A., Ganti A.K. Lung cancer-A global perspective. J. Surg. Oncol. 2017;115:550–554. doi: 10.1002/jso.24532. PubMed DOI
Cancer Today. [(accessed on 21 March 2024)]. Available online: https://gco.iarc.fr/
Barta J.A., Powell C.A., Wisnivesky J.P. Global Epidemiology of Lung Cancer. Ann. Glob. Health. 2019;85:8. doi: 10.5334/aogh.2419. PubMed DOI PMC
Bade B.C., Dela Cruz C.S. Lung Cancer 2020. Clin. Chest. Med. 2020;41:1–24. doi: 10.1016/j.ccm.2019.10.001. PubMed DOI
Hoy H., Lynch T., Beck M. Surgical Treatment of Lung Cancer. Crit. Care Nurs. Clin. N. Am. 2019;31:303–313. doi: 10.1016/j.cnc.2019.05.002. PubMed DOI
Manerikar A., Querrey M., Cerier E., Kim S., Odell D.D., Pesce L.L., Bharat A. Comparative Effectiveness of Surgical Approaches for Lung Cancer. J. Surg. Res. 2021;263:274–284. doi: 10.1016/j.jss.2020.10.020. PubMed DOI PMC
Bendixen M., Jørgensen O.D., Kronborg C., Andersen C., Licht P.B. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: A randomised controlled trial. Lancet Oncol. 2016;17:836–844. doi: 10.1016/S1470-2045(16)00173-X. PubMed DOI
Mercier O. VATS versus open thoracotomy for lung cancer resection: Is the game still running? Eur. J. Cardiothorac. Surg. 2022;62:ezac303. doi: 10.1093/ejcts/ezac303. PubMed DOI
Lim E., A Harris R., E McKeon H., Batchelor T.J., Dunning J., Shackcloth M., Anikin V., Naidu B., Belcher E., Loubani M., et al. Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT. Health Technol. Assess. 2022;26:1–162. doi: 10.3310/THBQ1793. PubMed DOI PMC
Gao H.-J., Jiang Z.-H., Gong L., Ma K., Ren P., Yu Z.-T., Wei Y.-C. Video-Assisted Vs Thoracotomy Sleeve Lobectomy for Lung Cancer: A Propensity Matched Analysis. Ann. Thorac. Surg. 2019;108:1072–1079. doi: 10.1016/j.athoracsur.2019.04.037. PubMed DOI
Couñago F., Luna J., Guerrero L.L., Vaquero B., Guillén-Sacoto M.C., González-Merino T., Taboada B., Díaz V., Rubio-Viqueira B., Díaz-Gavela A.A., et al. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions. World J. Clin. Oncol. 2019;10:318–339. doi: 10.5306/wjco.v10.i10.318. PubMed DOI PMC
Freeman B.S., Berger J.S. Anesthesiology Core Review. Part 1, Basic Exam. Mcgraw-Hill Education Medical; New York, NY, USA: 2014.
McDonald C.L., Cohen B.H., Medina Pérez G., Modest J.M., Kuris E.O., Born C. Pre-Operative Medications as a Predictor for Post-Operative Complications Following Geriatric Hip Fracture Surgery. Geriatr. Orthop. Surg. Rehabil. 2022;13:215145932210910. doi: 10.1177/21514593221091062. PubMed DOI PMC
Choi K.S., Jeong Y.M., Lee E., Kim K.I., Yee J., Lee B.K., Chung J.E., Rhie S.J., Gwak H.S. Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment. Aging Clin. Exp. Res. 2018;30:1177–1185. doi: 10.1007/s40520-018-0904-2. PubMed DOI
Lee C.-Y., Cheng Y.-D., Cheng W.-Y., Tsai T.-H., Huang K.-H. The Prevalence of Anticholinergic Drugs and Correlation with Pneumonia in Elderly Patients: A Population-Based Study in Taiwan. Int. J. Environ. Res. Public Health. 2020;17:6260. doi: 10.3390/ijerph17176260. PubMed DOI PMC
Zhang H.-X., Shen Y., Chen J., Zhang L., Lin W. Risk Factors of Pulmonary Complications After Minimally Invasive Surgery for Elderly Patients with Vertebral Compression Fractures. Ther. Clin. Risk Manag. 2020;16:7–15. doi: 10.2147/TCRM.S231383. PubMed DOI PMC
Seely A.J., Ivanovic J., Threader J., Al-Hussaini A., Al-Shehab D., Ramsay T., Gilbert S., Maziak D.E., Shamji F.M., Sundaresan R.S. Systematic classification of morbidity and mortality after thoracic surgery. Ann. Thorac. Surg. 2010;90:936–942. doi: 10.1016/j.athoracsur.2010.05.014. PubMed DOI
Jammer I., Wickboldt N., Sander M., Smith A., Schultz M.J., Pelosi P., Leva B., Rhodes A., Hoeft A., Walder B., et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine. Eur. J. Anaesthesiol. 2015;32:88–105. doi: 10.1097/EJA.0000000000000118. PubMed DOI
Schussler O., Alifano M., Dermine H., Strano S., Casetta A., Sepulveda S., Chafik A., Coignard S., Rabbat A., Regnard J.-F. Postoperative Pneumonia after Major Lung Resection. Am. J. Respir. Crit. Care Med. 2006;173:1161–1169. doi: 10.1164/rccm.200510-1556OC. PubMed DOI
Detillon D.D.E.M.A., Veen E.J. Postoperative Outcome After Pulmonary Surgery for Non-Small Cell Lung Cancer in Elderly Patients. Ann. Thorac. Surg. 2018;105:287–293. doi: 10.1016/j.athoracsur.2017.07.032. PubMed DOI
Yao L., Luo J., Liu L., Wu Q., Zhou R., Li L., Zhang C. Risk factors for postoperative pneumonia and prognosis in lung cancer patients after surgery. Medicine. 2021;100:e25295. doi: 10.1097/MD.0000000000025295. PubMed DOI PMC
Al-Ameri M., Bergman P., Franco-Cereceda A., Sartipy U. Video-assisted thoracoscopic versus open thoracotomy lobectomy: A Swedish nationwide cohort study. J. Thorac. Dis. 2018;10:3499–3506. doi: 10.21037/jtd.2018.05.177. PubMed DOI PMC
Guerrera F., Lyberis P., Lausi P.O., Cristofori R.C., Giobbe R., Molinatti M., Filosso P.L., Curcio C., Crisci R., Ruffini E. Does morbid obesity influence perioperative outcomes after video-assisted thoracic surgery (VATS) lobectomy for non-small cell lung cancer? Analysis of the Italian VATS group registry. Surg. Endosc. 2021;36:3567–3573. doi: 10.1007/s00464-021-08680-y. PubMed DOI PMC
Paul K.J., Walker R.L., Dublin S. Anticholinergic Medications and Risk of Community-Acquired Pneumonia in Elderly Adults: A Population-Based Case-Control Study. J. Am. Geriatr. Soc. 2015;63:476–485. doi: 10.1111/jgs.13327. PubMed DOI
Batihan G., Ceylan K.C., Usluer O., Kaya Ş.Ö. Video-Assisted Thoracoscopic Surgery vs Thoracotomy for Non-Small Cell Lung Cancer Greater Than 5 cm: Is VATS a feasible approach for large tumors? J. Cardiothorac. Surg. 2020;15:261. doi: 10.1186/s13019-020-01305-w. PubMed DOI PMC
Simonsen D.F., Søgaard M., Bozi I., Horsburgh C.R., Thomsen R.W. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir. Med. 2015;109:1340–1346. doi: 10.1016/j.rmed.2015.07.008. PubMed DOI
Lee J.Y., Jin S.-M., Lee C.-H., Lee B.J., Kang C.-H., Yim J.-J., Yang S.-C., Yoo C.-G., Han S.K., Kim J.H., et al. Risk factors of postoperative pneumonia after lung cancer surgery. J. Korean Med. Sci. 2011;26:979–984. doi: 10.3346/jkms.2011.26.8.979. PubMed DOI PMC
Ogawa F., Wang G., Matsui Y., Hara H., Iyoda A., Satoh Y. Risk factors for postoperative complications in the elderly with lung cancer. Asian Cardiovasc. Thorac. Ann. 2013;21:313–318. doi: 10.1177/0218492312457359. PubMed DOI
Tulinský L., Sengul I., Ihnát P., Ostruszka P., Toman D., Guňková P., Pelikán A., Sengul D. Obesity in cases undergoing the surgical procedure of lung lobectomy: Risk or benefit? Rev. Assoc. Med. Bras. 2022;68:1090–1095. doi: 10.1590/1806-9282.20220526. PubMed DOI PMC
Tulinský L., Mitták M., Tomášková H., Ostruszka P., Penka I., Ihnát P. Obesity paradox in patients undergoing lung lobectomy—Myth or reality? BMC Surg. 2018;18:61. doi: 10.1186/s12893-018-0395-2. PubMed DOI PMC
de Angelis P., Tan K.S., Chudgar N.P., Dycoco J., Adusumilli P.S., Bains M.S., Bott M.J., Downey R.J., Huang J., Isbell J.M., et al. Operative Time Is Associated with Postoperative Complications After Pulmonary Lobectomy. Ann. Surg. 2022;278:1259–1266. doi: 10.1097/SLA.0000000000005696. PubMed DOI PMC
Gómez-Hernández M.T., Forcada C., Varela G., Jiménez M.F. Operating time: An independent and modifiable risk factor for short-term complications after video-thoracoscopic pulmonary lobectomy. Eur. J. Cardiothorac. Surg. 2022;62:ezac503. doi: 10.1093/ejcts/ezac503. PubMed DOI